Abstract
In another move by a drug company into the realm of electronics-enabled health care, Novartis’s Alcon eye care division has agreed to license “smart lens” technology from Google. Developed by Google X, a Google “secret lab” focused on solving big global problems, the technology is a way to embed contact lenses with noninvasive sensors, microchips, and other electronics. Novartis envisions two applications for the technology. One is helping diabetic patients manage their disease by measuring glucose levels in eye fluid using a smart lens connected wirelessly to a mobile phone. At present, people with diabetes must draw blood and place it in a glucose measuring device. The other application is treating presbyopia, the loss of the eye’s ability to focus on close objects that occurs naturally with aging. When combined with refractive surgery, the smart lens has the potential to help restore the eye’s natural autofocus, according to the drugmaker. ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
